161 related articles for article (PubMed ID: 29358166)
21. Exosomes and the Prion Protein: More than One Truth.
Hartmann A; Muth C; Dabrowski O; Krasemann S; Glatzel M
Front Neurosci; 2017; 11():194. PubMed ID: 28469550
[TBL] [Abstract][Full Text] [Related]
22. Interaction between misfolded PrP and the ubiquitin-proteasome system in prion-mediated neurodegeneration.
Lin Z; Zhao D; Yang L
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):477-84. PubMed ID: 23449072
[TBL] [Abstract][Full Text] [Related]
23. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
Singh J; Udgaonkar JB
Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
[TBL] [Abstract][Full Text] [Related]
24. Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases.
Iraci N; Stincardini C; Barreca ML; Biasini E
Virus Res; 2015 Sep; 207():62-8. PubMed ID: 25456402
[TBL] [Abstract][Full Text] [Related]
25. Cellular prion protein: A co-receptor mediating neuronal cofilin-actin rod formation induced by β-amyloid and proinflammatory cytokines.
Walsh KP; Kuhn TB; Bamburg JR
Prion; 2014; 8(6):375-80. PubMed ID: 25426519
[TBL] [Abstract][Full Text] [Related]
26. Zebrafish prion protein PrP2 controls collective migration process during lateral line sensory system development.
Huc-Brandt S; Hieu N; Imberdis T; Cubedo N; Silhol M; Leighton PL; Domaschke T; Allison WT; Perrier V; Rossel M
PLoS One; 2014; 9(12):e113331. PubMed ID: 25436888
[TBL] [Abstract][Full Text] [Related]
27. Dextran sulfate sodium inhibits amyloid-β oligomer binding to cellular prion protein.
Aimi T; Suzuki K; Hoshino T; Mizushima T
J Neurochem; 2015 Aug; 134(4):611-7. PubMed ID: 25963375
[TBL] [Abstract][Full Text] [Related]
28. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
29. Altered prion protein glycosylation in the aging mouse brain.
Goh AX; Li C; Sy MS; Wong BS
J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
[TBL] [Abstract][Full Text] [Related]
30. Cerebrovascular disorders caused by hyperfibrinogenaemia.
Muradashvili N; Tyagi R; Tyagi N; Tyagi SC; Lominadze D
J Physiol; 2016 Oct; 594(20):5941-5957. PubMed ID: 27121987
[TBL] [Abstract][Full Text] [Related]
31. Cellular prion protein electron microscopy: attempts/limits and clues to a synaptic trait. Implications in neurodegeneration process.
Fournier JG
Cell Tissue Res; 2008 Apr; 332(1):1-11. PubMed ID: 18236081
[TBL] [Abstract][Full Text] [Related]
32. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
[TBL] [Abstract][Full Text] [Related]
33. Impact of the cellular prion protein on amyloid-β and 3PO-tau processing.
Schmitz M; Wulf K; Signore SC; Schulz-Schaeffer WJ; Kermer P; Bähr M; Wouters FS; Zafar S; Zerr I
J Alzheimers Dis; 2014; 38(3):551-65. PubMed ID: 24028865
[TBL] [Abstract][Full Text] [Related]
34. Prion protein and aging.
Gasperini L; Legname G
Front Cell Dev Biol; 2014; 2():44. PubMed ID: 25364751
[TBL] [Abstract][Full Text] [Related]
35. Protein misfolding cyclic amplification induces the conversion of recombinant prion protein to PrP oligomers causing neuronal apoptosis.
Yuan Z; Yang L; Chen B; Zhu T; Hassan MF; Yin X; Zhou X; Zhao D
J Neurochem; 2015 Jun; 133(5):722-9. PubMed ID: 25810062
[TBL] [Abstract][Full Text] [Related]
36. A Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases.
Imberdis T; Ayrolles-Torro A; Duarte Rodrigues A; Torrent J; Alvarez-Martinez MT; Kovacs GG; Verdier JM; Robitzer M; Perrier V
Mol Neurodegener; 2016 Jan; 11():11. PubMed ID: 26809712
[TBL] [Abstract][Full Text] [Related]
37. Aβ induces its own prion protein N-terminal fragment (PrPN1)-mediated neutralization in amorphous aggregates.
Béland M; Bédard M; Tremblay G; Lavigne P; Roucou X
Neurobiol Aging; 2014 Jul; 35(7):1537-48. PubMed ID: 24602510
[TBL] [Abstract][Full Text] [Related]
38. Lipid rafts: linking prion protein to zinc transport and amyloid-β toxicity in Alzheimer's disease.
Watt NT; Griffiths HH; Hooper NM
Front Cell Dev Biol; 2014; 2():41. PubMed ID: 25364748
[TBL] [Abstract][Full Text] [Related]
39. Amyloid-β precursor protein mutant zebrafish exhibit seizure susceptibility that depends on prion protein.
Kanyo R; Leighton PLA; Neil GJ; Locskai LF; Allison WT
Exp Neurol; 2020 Jun; 328():113283. PubMed ID: 32165257
[TBL] [Abstract][Full Text] [Related]
40. To develop with or without the prion protein.
Halliez S; Passet B; Martin-Lannerée S; Hernandez-Rapp J; Laude H; Mouillet-Richard S; Vilotte JL; Béringue V
Front Cell Dev Biol; 2014; 2():58. PubMed ID: 25364763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
